TB-500 es una fraccin sinttica relacionada con la timosina beta-4
KLOW adds a fourth peptide, KPV, for enhanced anti-inflammatory action
The phase 1b trial characterised them: mostly ecchymosis (bruising, in 79% of those affected) and redness (32%), all mild, and, critically, not dose-dependent
Cell culture was performed under aseptic conditions in Class II biosafety cabinets and incubation took place at 37 o C and 5% CO 2 in a humidified incubator
Beyond wound healing, BPC-157 helps protect the gastrointestinal tract, prevents stomach ulcers, and supports systemic repair across multiple tissue types
Combined, these studies involved fewer than 30 human subjects and lacked control groups none used a randomized, placebo-controlled design